Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Lab: Special Histochemical and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Botulinum Toxin Type A & Type B (DL34635) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Wheelchair Seating | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Lab: Special Histochemical and Immunohistochemical Stains | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: ApoE Genotype | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Trigger Point Injections (TPI) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Pain Management - injection of tendon sheaths, ligaments, bursa, and ganglion cysts | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Peripheral Nerve Blocks and Procedures for Chronic Pain | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Peripheral Nerve Blocks and Procedures for Chronic Pain | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Peripheral Nerve Blocks and Procedures for Chronic Pain | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Peripheral Nerve Blocks and Procedures for Chronic Pain | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Coverage of Intravenous Immune Globulin for Treatment of Primary Immune Deficiency Diseases in the Home Medicare Benefit Policy Manual, Chapter 15, 50.6 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38684 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Off-Label Use of Intravenous Immune Globulin (IVIG) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Total Joint Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Automated Detection and Quantification of Brain Magnetic Resonance Imaging | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Automated Detection and Quantification of Brain Magnetic Resonance Imaging | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Intravenous Immune Globulin (IVIg)-NCD 250.3 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments for MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |